Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.

In early 2022, Connor started a new medication called Nexviazyme, but each treatment took 13 hours. This summer, he received ...

Dr. Drucy Borowitz helped turn cystic fibrosis from a deadly childhood illness into a treatable condition, giving families ...

BioMarin Pharmaceutical BMRN reported third-quarter 2025 adjusted earnings per share (EPS) of 12 cents against the Zacks ...

Citizens JMP upgraded Spruce Biosciences (SPRB) to Outperform from Market Perform with a $254 price target The firm cites the company’s ...

Learn more about whether BioMarin Pharmaceutical Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Flatulence is an entirely normal process which occurs up to 20 times a day, often the sign of a healthy gut. But there are ...

Denali Therapeutics (($DNLI)) announced an update on their ongoing clinical study. Study Overview: Denali Therapeutics is conducting a Phase 2/3 ...

Background Fabry disease (FD) is an X linked lysosomal disorder with ventricular myocardial involvement that drives morbidity and mortality. Early diagnosis of cardiac involvement can be difficult.

This article was reviewed by Julia Switzer, MD, FACOG. Menopause and Body Odor Key takeaways: Menopause body odor can happen ...

Human growth hormone therapy has become one of the most talked-about topics in modern wellness. From celebrities to fitness ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.